Lab
Watertown Medical Center LLC
Watertown Medical Center LLC was paid $6.31M by Medicaid between Jan 2018 and Dec 2024, across 181 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.
33Billing provider infoWATERTOWN MEDICAL CENTER LLC
WATERTOWN, WI 53098
WATERTOWN, WI 53098
33aNPI1992776041assigned 01/27/2006
33bProvider typeClinical Medical Laboratory
28Total paid$6.31M
24GClaims348,204
24DCodes billed181
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Wisconsin
Rank by total paid#12 of 75
Median peer was paid$106K
This provider vs. median59×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TRAYLOR, JOHNETTA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,966 | $979K | |
| 2019 | 49,112 | $854K | |
| 2020 | 48,329 | $866K | |
| 2021 | 53,396 | $953K | |
| 2022 | 52,233 | $879K | |
| 2023 | 60,170 | $1.04M | |
| 2024incomplete | 41,998 | $740K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 14,747 | 12,319 | $842K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.7% | 11,068 | 8,668 | $486K |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.5% | 4,506 | 3,217 | $477K |
| 80053 | Comprehensive metabolic panel | 5.5% | 16,297 | 12,449 | $346K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.2% | 4,357 | 3,752 | $268K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.8% | 3,731 | 3,294 | $239K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.1% | 15,941 | 4,105 | $193K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.5% | 1,553 | 1,332 | $158K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.4% | 4,195 | 3,690 | $149K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 2,237 | 1,850 | $143K |
| 81001 | 2.2% | 11,115 | 8,848 | $139K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.2% | 4,968 | 3,794 | $138K |
169 more codes
| 99285 | Emergency room visit (most serious) | 2.1% | 3,673 | $134K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 2,390 | $127K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 17,350 | $125K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.9% | 19,649 | $121K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.7% | 2,441 | $105K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.6% | 2,079 | $104K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 1,509 | $97K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.5% | 1,263 | $92K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.4% | 9,470 | $88K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.4% | 1,279 | $88K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 2,497 | $82K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.2% | 2,466 | $79K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.1% | 1,780 | $71K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 1,686 | $68K |
| 87081 | 1.1% | 2,697 | $68K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,053 | $62K |
| 86710 | <1% | 3,154 | $60K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,052 | $60K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,434 | $57K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 995 | $52K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,703 | $46K |
| 80061 | Lipid panel | <1% | 3,461 | $44K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,124 | $43K |
| 84484 | <1% | 5,233 | $43K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,133 | $37K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 466 | $36K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,409 | $36K |
| 81025 | <1% | 3,759 | $36K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,754 | $34K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,144 | $34K |
| 85027 | <1% | 4,225 | $32K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 560 | $30K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 825 | $29K |
| 84145 | <1% | 1,700 | $23K | |
| 83690 | <1% | 4,864 | $23K | |
| 82962 | <1% | 3,000 | $22K | |
| G0378 | Hospital observation service, per hour | <1% | 1,018 | $21K |
| 76801 | <1% | 314 | $19K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,607 | $18K |
| 83880 | <1% | 885 | $17K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 411 | $16K |
| 83735 | <1% | 4,088 | $16K | |
| 85610 | <1% | 3,483 | $15K | |
| 83605 | <1% | 2,369 | $14K | |
| 87480 | <1% | 617 | $13K | |
| 80305 | <1% | 1,131 | $12K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,379 | $12K |
| 85380 | <1% | 1,591 | $11K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 625 | $11K |
| 87660 | <1% | 617 | $10K | |
| 87807 | <1% | 279 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 161 | $9K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 139 | $9K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 438 | $9K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 241 | $8K |
| 97162 | <1% | 326 | $8K | |
| 97161 | <1% | 789 | $7K | |
| 76830 | Ultrasound, transvaginal | <1% | 249 | $7K |
| 84703 | <1% | 844 | $7K | |
| 87510 | <1% | 617 | $7K | |
| 80179 | <1% | 423 | $7K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 496 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,235 | $6K |
| 74018 | <1% | 806 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 82 | $6K |
| 86803 | <1% | 441 | $6K | |
| 86703 | <1% | 445 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 957 | $6K |
| 86850 | <1% | 1,059 | $6K | |
| 86140 | <1% | 1,413 | $6K | |
| 86780 | <1% | 603 | $5K | |
| 87186 | <1% | 823 | $5K | |
| 82553 | <1% | 1,168 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 124 | $5K |
| 80143 | <1% | 477 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 6,774 | $5K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 152 | $4K |
| 84439 | <1% | 453 | $4K | |
| 86900 | <1% | 1,220 | $4K | |
| 87340 | <1% | 423 | $4K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 45 | $4K |
| 86901 | <1% | 1,333 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 133 | $3K |
| 87653 | <1% | 66 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,951 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,427 | $3K |
| 80050 | General health panel | <1% | 297 | $3K |
| 73630 | <1% | 582 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 75 | $2K |
| 82950 | <1% | 61 | $2K | |
| 12001 | <1% | 13 | $2K | |
| 86592 | <1% | 221 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,412 | $2K |
| 87077 | <1% | 277 | $1K | |
| 82803 | <1% | 76 | $1K | |
| 85652 | <1% | 581 | $1K | |
| 73610 | <1% | 500 | $1K | |
| 90837 | Psychotherapy session, about an hour | <1% | 629 | $1K |
| 72100 | <1% | 125 | $1K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 684 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 19,759 | $1K |
| 82043 | <1% | 109 | $966.73 | |
| 82565 | <1% | 120 | $943.75 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 16 | $943.73 |
| 87075 | <1% | 48 | $889.05 | |
| 87040 | <1% | 109 | $886.93 | |
| 85730 | <1% | 263 | $830.39 | |
| 84702 | <1% | 66 | $814.21 | |
| 82150 | <1% | 185 | $794.90 | |
| 85007 | <1% | 171 | $759.38 | |
| 73030 | <1% | 187 | $697.13 | |
| 86762 | <1% | 38 | $519.76 | |
| 82550 | <1% | 78 | $517.10 | |
| 82607 | <1% | 61 | $504.43 | |
| 82947 | <1% | 161 | $495.37 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,373 | $402.00 |
| 73110 | <1% | 66 | $392.15 | |
| 80320 | <1% | 614 | $371.94 | |
| 82728 | <1% | 13 | $365.69 | |
| 82330 | <1% | 40 | $274.62 | |
| 94761 | <1% | 4,257 | $214.61 | |
| 73562 | <1% | 75 | $212.73 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 387 | $209.77 |
| 0352U | <1% | 289 | $173.78 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 2,391 | $158.07 |
| 83550 | <1% | 25 | $157.71 | |
| 84132 | <1% | 108 | $153.16 | |
| 73130 | <1% | 100 | $145.41 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 31 | $134.31 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,753 | $99.48 |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 12 | $86.03 |
| 36000 | <1% | 76 | $76.23 | |
| 73502 | <1% | 33 | $67.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,424 | $65.13 |
| 84295 | <1% | 21 | $34.89 | |
| 73090 | <1% | 20 | $33.76 | |
| 0353U | <1% | 146 | $21.36 | |
| 96376 | <1% | 649 | $13.90 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,745 | $8.81 |
| 94760 | <1% | 1,890 | $7.07 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,331 | $5.76 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,546 | $4.03 |
| 90686 | <1% | 69 | $2.50 | |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | <1% | 70 | $0.64 |
| A9270 | Non-covered item or service | <1% | 1,397 | $0.39 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 992 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 153 | $0.00 |
| 92134 | 0% | 68 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 30 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 145 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 72 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 96 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 13 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 13 | $0.00 |
| 94664 | 0% | 13 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 64 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 1,283 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 1,398 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 13 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 1,603 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 112 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 79 | $0.00 |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | 0% | 238 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 61 | $0.00 |
| J3490 | Unclassified drugs | 0% | 34 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 32 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 51 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 32 | $0.00 |
| 90674 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTRAYLOR, JOHNETTA (AO)
Parent organizationLIFEPOINT HEALTH INC
| Provider | Location | Paid |
|---|---|---|
| Logan General Hospital LLC | Logan, WV | $43.43M |
| Phc-Cleveland LLC | Cleveland, MS | $23.43M |
| Hartsville, LLC | Hartsville, SC | $18.42M |
| Logan Memorial Hospital LLC | Russellville, KY | $14.29M |
| Southwestern Medical Center, LLC | Lawton, OK | $9.40M |
| Palestine Principal Healthcare Limited Partnership | Palestine, TX | $6.80M |
| Amg - Livingston, LLC | Livingston, TN | $5.52M |
| Logan General Hospital LLC | Logan, WV | $4.91M |
| ST. Joseph Hospital LLC | Lewiston, ID | $4.67M |
| Riverton Memorial Hospital LLC | Riverton, WY | $4.65M |
| Livingston Regional Hospital LLC | Livingston, TN | $4.33M |
| Hartsville Medical Group LLC | Hartsville, SC | $4.16M |
| Mexia Principal Healthcare Limited Partnership | Mexia, TX | $2.19M |
| Palestine Principal Healthcare Limited Partnership | Palestine, TX | $1.27M |
| Texas Specialty Physicians | Palestine, TX | $1.26M |
| ST Joseph Hospital LLC | Lewiston, ID | $1.10M |
| Watertown Physician Practices LLC | Watertown, WI | $244K |
| Watertown Physician Practices LLC | Watertown, WI | $175K |
| Amg-Livingston LLC | Livingston, TN | $165K |
| Watertown Physician Practices LLC | Watertown, WI | $149K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.